Sponsor:
Mayo Clinic
Code:
NCT07381179
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07381179
Start date
Nov 13, 2025
Status verified date
Jan, 2026
Completion date
Dec 13, 2027
Anticipated
Primary completion date
Dec 13, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Central contacts
Susan Steinmetz
507-266-5280Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Susan Steinmetz
507-266-5280Principal Investigator:
Ugur Sener, MD
Sponsor
Mayo Clinic
Last update posted
Feb 2, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-02-02.